Movano Inc. (MOVE)
USD 5.75
(-4.49%)
USD 5.75
(-4.49%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 5.97 Million USD | 12.09% |
| 2022 | 5.32 Million USD | 50.72% |
| 2021 | 3.53 Million USD | -76.66% |
| 2020 | 15.14 Million USD | 1601.69% |
| 2019 | 890 Thousand USD | 127.62% |
| 2018 | 391 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 4.04 Million USD | -38.79% |
| 2024 Q1 | 6.61 Million USD | 10.73% |
| 2023 Q2 | 4.74 Million USD | -15.42% |
| 2023 FY | 5.97 Million USD | 12.09% |
| 2023 Q4 | 5.97 Million USD | 5.72% |
| 2023 Q3 | 5.64 Million USD | 19.05% |
| 2023 Q1 | 5.61 Million USD | 5.29% |
| 2022 Q1 | 3.1 Million USD | -12.22% |
| 2022 FY | 5.32 Million USD | 50.72% |
| 2022 Q4 | 5.32 Million USD | 11.09% |
| 2022 Q3 | 4.79 Million USD | 23.13% |
| 2022 Q2 | 3.89 Million USD | 25.52% |
| 2021 Q3 | 3.18 Million USD | 47.37% |
| 2021 FY | 3.53 Million USD | -76.66% |
| 2021 Q4 | 3.53 Million USD | 10.85% |
| 2021 Q2 | 2.16 Million USD | 1.64% |
| 2021 Q1 | 2.12 Million USD | -85.94% |
| 2020 Q4 | 15.14 Million USD | 20.13% |
| 2020 Q3 | 12.6 Million USD | 0.0% |
| 2020 Q1 | - USD | -100.0% |
| 2020 FY | 15.14 Million USD | 1601.69% |
| 2019 Q4 | 890 Thousand USD | 0.0% |
| 2019 FY | 890 Thousand USD | 127.62% |
| 2018 FY | 391 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Acutus Medical, Inc. | 54.83 Million USD | 89.11% |
| Axonics, Inc. | 82.35 Million USD | 92.749% |
| INVO Bioscience, Inc. | 19.99 Million USD | 70.132% |
| CVRx, Inc. | 39.28 Million USD | 84.797% |
| iRhythm Technologies, Inc. | 223.04 Million USD | 97.323% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -87.684% |
| MaxCyte, Inc. | 36.1 Million USD | 83.46% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | 72.208% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | 95.183% |
| Sintx Technologies, Inc. | 6.59 Million USD | 9.419% |
| Accelerate Diagnostics, Inc. | 51.25 Million USD | 88.348% |
| Apyx Medical Corporation | 52.31 Million USD | 88.585% |
| Cutera, Inc. | 518.12 Million USD | 98.847% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -11.793% |
| NeuroPace, Inc. | 86.99 Million USD | 93.135% |
| IRIDEX Corporation | 24.91 Million USD | 76.03% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | 93.198% |
| enVVeno Medical Corporation | 2.43 Million USD | -145.257% |
| TELA Bio, Inc. | 59.16 Million USD | 89.907% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | 99.065% |
| UFP Technologies, Inc. | 118.04 Million USD | 94.941% |
| Modular Medical, Inc. | 2.27 Million USD | -162.852% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | 79.637% |
| LENSAR, Inc. | 22.4 Million USD | 73.35% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 99.728% |
| Surmodics, Inc. | 65.82 Million USD | 90.927% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | 42.126% |
| Inogen, Inc. | 121.38 Million USD | 95.08% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -256.75% |
| RxSight, Inc. | 22.18 Million USD | 73.085% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1304.248% |
| Lucid Diagnostics Inc. | 29.58 Million USD | 79.811% |
| Nano-X Imaging Ltd. | 23.13 Million USD | 74.185% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -1304.248% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -145.832% |
| Cytek Biosciences, Inc. | 104.6 Million USD | 94.291% |
| Alphatec Holdings, Inc. | 703.48 Million USD | 99.151% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | 76.546% |
| Dynatronics Corporation | 11.78 Million USD | 49.304% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | 88.44% |
| InMode Ltd. | 75.91 Million USD | 92.133% |
| Bruker Corporation | 2.83 Billion USD | 99.789% |
| Orthofix Medical Inc. | 326.58 Million USD | 98.171% |
| FONAR Corporation | 57.45 Million USD | 89.606% |
| BioSig Technologies, Inc. | 4.68 Million USD | -27.471% |
| Envoy Medical, Inc. | 9.4 Million USD | 36.482% |
| Align Technology, Inc. | 2.45 Billion USD | 99.757% |
| Anika Therapeutics, Inc. | 58.36 Million USD | 89.768% |
| Talis Biomedical Corporation | 29.22 Million USD | 79.565% |
| Cerus Corporation | 144.3 Million USD | 95.862% |
| 908 Devices Inc. | 37.49 Million USD | 84.07% |
| Nemaura Medical Inc. | 26.37 Million USD | 77.359% |
| Outset Medical, Inc. | 190.91 Million USD | 96.872% |
| NanoVibronix, Inc. | 2.68 Million USD | -122.338% |
| Venus Concept Inc. | 107.1 Million USD | 94.424% |
| Telesis Bio, Inc. | 40.87 Million USD | 85.389% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | 94.76% |
| Quipt Home Medical Corp. | 136.29 Million USD | 95.618% |
| IRadimed Corporation | 20.73 Million USD | 71.2% |
| Tenon Medical, Inc. | 5.56 Million USD | -7.275% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -67.189% |
| Pulmonx Corporation | 60.63 Million USD | 90.151% |
| iCAD, Inc. | 8 Million USD | 25.359% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | 52.941% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -223.176% |
| Viemed Healthcare, Inc. | 40.79 Million USD | 85.359% |
| SI-BONE, Inc. | 61.05 Million USD | 90.218% |
| Semler Scientific, Inc. | 6.27 Million USD | 4.753% |
| Biotricity, Inc. | 35.91 Million USD | 83.374% |
| Cytosorbents Corporation | 29.98 Million USD | 80.084% |
| DexCom, Inc. | 4.19 Billion USD | 99.858% |
| ZimVie Inc. | 795.85 Million USD | 99.25% |
| Aethlon Medical, Inc. | 2.47 Million USD | -140.84% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | 50.059% |
| IceCure Medical Ltd | 4.24 Million USD | -40.617% |
| PAVmed Inc | 57.13 Million USD | 89.548% |
| Sight Sciences, Inc. | 46.43 Million USD | 87.139% |
| Insulet Corporation | 1.85 Billion USD | 99.678% |
| Profound Medical Corp. | 12.66 Million USD | 52.85% |
| electroCore, Inc. | 8.94 Million USD | 33.236% |
| Bioventus Inc. | 589.79 Million USD | 98.987% |
| InspireMD, Inc. | 8.14 Million USD | 26.652% |
| PAVmed Inc. | 57.13 Million USD | 89.548% |
| Nuwellis, Inc. | 6.78 Million USD | 11.917% |
| OrthoPediatrics Corp. | 72.56 Million USD | 91.77% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | 50.059% |
| BrainsWay Ltd. | 15.31 Million USD | 61.003% |
| BIOLASE, Inc. | 35.34 Million USD | 83.105% |
| Beyond Air, Inc. | 29.77 Million USD | 79.943% |
| AxoGen, Inc. | 101.16 Million USD | 94.097% |
| Inari Medical, Inc. | 209.32 Million USD | 97.147% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -173.217% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -235.694% |
| AdaptHealth Corp. | 3.15 Billion USD | 99.811% |
| Quanterix Corporation | 78.08 Million USD | 92.352% |
| Viveve Medical, Inc. | 10.84 Million USD | 44.943% |
| LivaNova PLC | 1.15 Billion USD | 99.482% |
| Co-Diagnostics, Inc. | 17.63 Million USD | 66.134% |
| Varex Imaging Corporation | 668.6 Million USD | 99.107% |
| Vivani Medical, Inc. | 25.03 Million USD | 76.146% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -46.949% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -67.189% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -22.252% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | 99.428% |
| TransMedics Group, Inc. | 568.84 Million USD | 98.95% |
| ReWalk Robotics Ltd. | 16.68 Million USD | 64.201% |
| NeuroMetrix, Inc. | 1.33 Million USD | -347.97% |
| Spectral AI, Inc. | 12.4 Million USD | 51.843% |
| Hyperfine, Inc. | 9.8 Million USD | 39.061% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | 97.614% |
| Biomerica, Inc. | 2.66 Million USD | -124.258% |
| Bone Biologics Corporation | 831.4 Thousand USD | -618.305% |
| AVITA Medical, Inc. | 19.86 Million USD | 69.938% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -202.582% |
| Silk Road Medical, Inc | 114.15 Million USD | 94.769% |